Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Retinal Biologics Market, by Indication
1.4.2 Europe Retinal Biologics Market, by Drug Class
1.4.3 Europe Retinal Biologics Market, by Distribution Channel
1.4.4 Europe Retinal Biologics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies deployed in Retinal Biologics Market
Chapter 5. Europe Retinal Biologics Market by Indication
5.1 Europe Macular Degeneration Market by Country
5.2 Europe Diabetic Retinopathy Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Retinal Biologics Market by Drug Class
6.1 Europe VEGF-A Antagonist Market by Country
6.2 Europe Others Market by Country
Chapter 7. Europe Retinal Biologics Market by Distribution Channel
7.1 Europe Hospital Pharmacy Market by Country
7.2 Europe Retail Pharmacy Market by Country
7.3 Europe Online Pharmacy Market by Country
Chapter 8. Europe Retinal Biologics Market by Country
8.1 Germany Retinal Biologics Market
8.1.1 Germany Retinal Biologics Market by Indication
8.1.2 Germany Retinal Biologics Market by Drug Class
8.1.3 Germany Retinal Biologics Market by Distribution Channel
8.2 UK Retinal Biologics Market
8.2.1 UK Retinal Biologics Market by Indication
8.2.2 UK Retinal Biologics Market by Drug Class
8.2.3 UK Retinal Biologics Market by Distribution Channel
8.3 France Retinal Biologics Market
8.3.1 France Retinal Biologics Market by Indication
8.3.2 France Retinal Biologics Market by Drug Class
8.3.3 France Retinal Biologics Market by Distribution Channel
8.4 Russia Retinal Biologics Market
8.4.1 Russia Retinal Biologics Market by Indication
8.4.2 Russia Retinal Biologics Market by Drug Class
8.4.3 Russia Retinal Biologics Market by Distribution Channel
8.5 Spain Retinal Biologics Market
8.5.1 Spain Retinal Biologics Market by Indication
8.5.2 Spain Retinal Biologics Market by Drug Class
8.5.3 Spain Retinal Biologics Market by Distribution Channel
8.6 Italy Retinal Biologics Market
8.6.1 Italy Retinal Biologics Market by Indication
8.6.2 Italy Retinal Biologics Market by Drug Class
8.6.3 Italy Retinal Biologics Market by Distribution Channel
8.7 Rest of Europe Retinal Biologics Market
8.7.1 Rest of Europe Retinal Biologics Market by Indication
8.7.2 Rest of Europe Retinal Biologics Market by Drug Class
8.7.3 Rest of Europe Retinal Biologics Market by Distribution Channel
Chapter 9. Company Profiles
9.1 Novartis AG
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Amgen, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 AbbVie, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Approvals & Trials:
9.3.6 SWOT Analysis
9.4 Bayer AG
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Regeneron Pharmaceuticals, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Research & Development Expense
9.5.4 SWOT Analysis
9.6 Santen Pharmaceutical Co., Ltd.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 SWOT Analysis
9.7 Bausch Health Companies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Approvals & Trials:
9.7.5.3 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 F. Hoffmann-La Roche Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Approvals & Trials:
9.8.6 SWOT Analysis
9.9 MeiraGTx Holdings plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expenses
9.9.4 SWOT Analysis
9.10. Oxurion NV
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Research & Development Expenses
9.10.4 SWOT Analysis



List of Figures

FIG 1 Methodology for the research
FIG 2 Europe Retinal Biologics Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Retinal Biologics Market
FIG 4 Porter’s Five Forces Analysis - Retinal Biologics Market
FIG 5 Europe Retinal Biologics Market share by Indication, 2022
FIG 6 Europe Retinal Biologics Market share by Indication, 2030
FIG 7 Europe Retinal Biologics Market by Indication, 2019 - 2030, USD Million
FIG 8 Europe Retinal Biologics Market share by Drug Class, 2022
FIG 9 Europe Retinal Biologics Market share by Drug Class, 2030
FIG 10 Europe Retinal Biologics Market by Drug Class, 2019 - 2030, USD Million
FIG 11 Europe Retinal Biologics Market share by Distribution Channel, 2022
FIG 12 Europe Retinal Biologics Market share by Distribution Channel, 2030
FIG 13 Europe Retinal Biologics Market by Distribution Channel, 2019 - 2030, USD Million
FIG 14 Europe Retinal Biologics Market share by Country, 2022
FIG 15 Europe Retinal Biologics Market share by Country, 2030
FIG 16 Europe Retinal Biologics Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Novartis AG
FIG 18 Swot Analysis: Amgen, Inc.
FIG 19 Swot Analysis: AbbVie, Inc.
FIG 20 Swot Analysis: Bayer AG
FIG 21 Swot Analysis: Regeneron Pharmaceuticals, Inc.
FIG 22 Swot Analysis: Santen Pharmaceutical Co., Ltd.
FIG 23 Recent strategies and developments: Bausch Health Companies, Inc.
FIG 24 Swot Analysis: Bausch Health Companies, Inc.
FIG 25 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 26 Swot Analysis: MeiraGTx Holdings plc
FIG 27 Swot Analysis: Oxurion NV

List of Tables

TABLE 1 Europe Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 2 Europe Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 3 Europe Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 4 Europe Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 5 Europe Macular Degeneration Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Macular Degeneration Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Diabetic Retinopathy Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Diabetic Retinopathy Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 12 Europe Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 13 Europe VEGF-A Antagonist Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe VEGF-A Antagonist Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 Europe Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 19 Europe Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Retinal Biologics Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Retinal Biologics Market by Country, 2023 - 2030, USD Million
TABLE 27 Germany Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 28 Germany Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 29 Germany Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 30 Germany Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 31 Germany Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 32 Germany Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 33 Germany Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 Germany Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 35 UK Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 36 UK Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 37 UK Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 38 UK Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 39 UK Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 40 UK Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 41 UK Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 UK Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 43 France Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 44 France Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 45 France Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 46 France Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 47 France Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 48 France Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 49 France Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 France Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 51 Russia Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 52 Russia Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 53 Russia Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 54 Russia Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 55 Russia Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 56 Russia Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 57 Russia Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Russia Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 59 Spain Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 60 Spain Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 61 Spain Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 62 Spain Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 63 Spain Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 64 Spain Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 65 Spain Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 Spain Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 67 Italy Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 68 Italy Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 69 Italy Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 70 Italy Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 71 Italy Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 72 Italy Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 73 Italy Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Italy Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 75 Rest of Europe Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 76 Rest of Europe Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 77 Rest of Europe Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 78 Rest of Europe Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 79 Rest of Europe Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 80 Rest of Europe Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 81 Rest of Europe Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Rest of Europe Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 83 Key Information – Novartis AG
TABLE 84 Key Information – Amgen, Inc.
TABLE 85 Key information – AbbVie, Inc.
TABLE 86 Key Information – Bayer AG
TABLE 87 Key Information – Regeneron Pharmaceuticals, Inc.
TABLE 88 Key Information – Santen Pharmaceutical Co., Ltd.
TABLE 89 key information – Bausch Health Companies, Inc.
TABLE 90 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 91 Key Information – MeiraGTx Holdings plc
TABLE 92 Key Information – Oxurion NV